相关实验视频

Updated: Jul 4, 2025

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

用诱导多能干细胞建模原始和最终的红色素形成

Giulia Pavani^1,2, Joshua G Klein¹, Catriana C Nations^1,3

¹Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA.

|January 30, 2024

概括

人类诱导的多能干细胞 (iPSCs) 可以模拟原始和最终的红细胞 (RBC) 发育. 对比iPSC衍生的红细胞揭示了不同的功能和基因表达特征,这对于疾病建模和输血产品至关重要.

科学领域:

血液学血液学血液学
干细胞生物学干细胞生物学
发展生物学发展生物学

背景情况:

红色甲状腺细胞通过具有独特特征的原始和最终的造血波发育.
人类诱导的多能干细胞 (iPSCs) 为研究红细胞 (RBC) 发育提供了一个模型,特别是后原始造血.
从iPSCs生成确定的造血原体,可以直接与来自同源源的原始红细胞进行比较.

研究的目的:

为了比较来自iPSC和胎儿肝细胞的原始和最终红细胞.
研究原始和最终红细胞之间的功能和转录组差异.
评估iPSCs在建模遗传血液病和开发输血产品方面的实用性.

主要方法:

从从胎儿肝细胞衍生的iPSC产生的同源原始和最终红细胞.
进行功能测试以比较红细胞特征.
使用单细胞RNA测序 (scRNA-seq) 进行转录组概况.
在iPSC系列中引入了KLF1的病原性突变,以研究疾病特异性变化.

主要成果:

原始的红细胞表现出减少的增殖,更大的尺寸,没有达菲抗原表达,和更高的胚胎球蛋白表达相比,明确的红细胞.
scRNA-seq揭示了胎儿肝脏和iPSC衍生的确定的红细胞之间的高度相似性,原始红细胞具有不同的基因表达模式.
具有KLF1突变的iPSC线条显示出确定的红细胞特异性表型变化.

结论:

这项研究为原始和最终的红色素形成之间的差异提供了新的见解.
强调在使用iPSC用于疾病建模时考虑造血本体学的重要性.
胎儿肝脏和iPSC衍生的最终红细胞之间的相似性支持它们在诊断和输血应用中的潜力.

更多相关视频

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Published on: June 16, 2019

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.